DARPP-32 and CREB are present in type 2 iodothyronine deiodinase-producing tanycytes: Implications for the regulation of type 2 deiodinase activity

Csaba Fekete, Emese Mihály, Sorin Herscovici, Jeremy Salas, Helen Tu, P. Reed Larsen, Ronald M. Lechan

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Type 2 iodothyronine deiodinase, an enzyme involved in the conversion of thyroxin to the biologically active 3,5,3'-triiodothyronine, is highly concentrated in a group of specialized ependymal cells, tanycytes, lining the wall and floor of the third ventricle. As this distribution is highly reminiscent of the distribution of cells containing the phosphatase inhibitor, DARPP-32, we raised the possibility that these two proteins may coexist in tanycytes and that DARPP-32 may modulate type 2 deiodinase activity by regulating the phosphorylation state of the cAMP regulatory factor, CREB. To address this question, double-labeling histochemical studies were performed for type 2 deiodinase mRNA and DARPP-32 immunoreactivity (IR), or DARPP-32- and CREB-IR in the same tissue sections. Type 2 deiodinase mRNA was found in the cell bodies of all DARPP-32-immunolabeled tanycytes. Both type 2 deiodinase mRNA and DARPP-32-IR also extended into tanycyte processes that ramified in the arcuate nucleus and median eminence, in close association with blood vessels and portal capillaries. In contrast, type 2 deiodinase mRNA was not present in the same cells that contained DARPP-32-IR in the pituitary gland. All tanycytes containing DARPP-32-IR also contained CREB-IR in their nucleus. Since type 2 deiodinase activity can be induced by substances that increase cAMP, we hypothesize that DARPP-32 may regulate the activity of type 2 deiodinase by prolonging the activation of CREB. Selectivity for the colocalization of these factors to tanycytes but not the pituitary gland, may explain the heterogeneous response of type 2 deiodinase activity in these two loci in response to specific stimuli such as fasting. Themes: Endocrine and autonomic regulation. Topics: Neuroendocrine regulation: other. Copyright (C) 2000 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)154-161
Number of pages8
JournalBrain Research
Volume862
Issue number1-2
DOIs
Publication statusPublished - Apr 17 2000

Fingerprint

Ependymoglial Cells
Iodide Peroxidase
Messenger RNA
Pituitary Gland
Median Eminence
Arcuate Nucleus of Hypothalamus
Third Ventricle
Triiodothyronine
Thyroxine
Phosphoric Monoester Hydrolases
Blood Vessels
Fasting
Phosphorylation

Keywords

  • CREB
  • DARPP-32
  • Tanycyte
  • Type 2 iodothyronine deiodinase

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

DARPP-32 and CREB are present in type 2 iodothyronine deiodinase-producing tanycytes : Implications for the regulation of type 2 deiodinase activity. / Fekete, Csaba; Mihály, Emese; Herscovici, Sorin; Salas, Jeremy; Tu, Helen; Larsen, P. Reed; Lechan, Ronald M.

In: Brain Research, Vol. 862, No. 1-2, 17.04.2000, p. 154-161.

Research output: Contribution to journalArticle

Fekete, Csaba ; Mihály, Emese ; Herscovici, Sorin ; Salas, Jeremy ; Tu, Helen ; Larsen, P. Reed ; Lechan, Ronald M. / DARPP-32 and CREB are present in type 2 iodothyronine deiodinase-producing tanycytes : Implications for the regulation of type 2 deiodinase activity. In: Brain Research. 2000 ; Vol. 862, No. 1-2. pp. 154-161.
@article{5a31bb50d8844747b61de637bc03a40a,
title = "DARPP-32 and CREB are present in type 2 iodothyronine deiodinase-producing tanycytes: Implications for the regulation of type 2 deiodinase activity",
abstract = "Type 2 iodothyronine deiodinase, an enzyme involved in the conversion of thyroxin to the biologically active 3,5,3'-triiodothyronine, is highly concentrated in a group of specialized ependymal cells, tanycytes, lining the wall and floor of the third ventricle. As this distribution is highly reminiscent of the distribution of cells containing the phosphatase inhibitor, DARPP-32, we raised the possibility that these two proteins may coexist in tanycytes and that DARPP-32 may modulate type 2 deiodinase activity by regulating the phosphorylation state of the cAMP regulatory factor, CREB. To address this question, double-labeling histochemical studies were performed for type 2 deiodinase mRNA and DARPP-32 immunoreactivity (IR), or DARPP-32- and CREB-IR in the same tissue sections. Type 2 deiodinase mRNA was found in the cell bodies of all DARPP-32-immunolabeled tanycytes. Both type 2 deiodinase mRNA and DARPP-32-IR also extended into tanycyte processes that ramified in the arcuate nucleus and median eminence, in close association with blood vessels and portal capillaries. In contrast, type 2 deiodinase mRNA was not present in the same cells that contained DARPP-32-IR in the pituitary gland. All tanycytes containing DARPP-32-IR also contained CREB-IR in their nucleus. Since type 2 deiodinase activity can be induced by substances that increase cAMP, we hypothesize that DARPP-32 may regulate the activity of type 2 deiodinase by prolonging the activation of CREB. Selectivity for the colocalization of these factors to tanycytes but not the pituitary gland, may explain the heterogeneous response of type 2 deiodinase activity in these two loci in response to specific stimuli such as fasting. Themes: Endocrine and autonomic regulation. Topics: Neuroendocrine regulation: other. Copyright (C) 2000 Elsevier Science B.V.",
keywords = "CREB, DARPP-32, Tanycyte, Type 2 iodothyronine deiodinase",
author = "Csaba Fekete and Emese Mih{\'a}ly and Sorin Herscovici and Jeremy Salas and Helen Tu and Larsen, {P. Reed} and Lechan, {Ronald M.}",
year = "2000",
month = "4",
day = "17",
doi = "10.1016/S0006-8993(00)02105-3",
language = "English",
volume = "862",
pages = "154--161",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - DARPP-32 and CREB are present in type 2 iodothyronine deiodinase-producing tanycytes

T2 - Implications for the regulation of type 2 deiodinase activity

AU - Fekete, Csaba

AU - Mihály, Emese

AU - Herscovici, Sorin

AU - Salas, Jeremy

AU - Tu, Helen

AU - Larsen, P. Reed

AU - Lechan, Ronald M.

PY - 2000/4/17

Y1 - 2000/4/17

N2 - Type 2 iodothyronine deiodinase, an enzyme involved in the conversion of thyroxin to the biologically active 3,5,3'-triiodothyronine, is highly concentrated in a group of specialized ependymal cells, tanycytes, lining the wall and floor of the third ventricle. As this distribution is highly reminiscent of the distribution of cells containing the phosphatase inhibitor, DARPP-32, we raised the possibility that these two proteins may coexist in tanycytes and that DARPP-32 may modulate type 2 deiodinase activity by regulating the phosphorylation state of the cAMP regulatory factor, CREB. To address this question, double-labeling histochemical studies were performed for type 2 deiodinase mRNA and DARPP-32 immunoreactivity (IR), or DARPP-32- and CREB-IR in the same tissue sections. Type 2 deiodinase mRNA was found in the cell bodies of all DARPP-32-immunolabeled tanycytes. Both type 2 deiodinase mRNA and DARPP-32-IR also extended into tanycyte processes that ramified in the arcuate nucleus and median eminence, in close association with blood vessels and portal capillaries. In contrast, type 2 deiodinase mRNA was not present in the same cells that contained DARPP-32-IR in the pituitary gland. All tanycytes containing DARPP-32-IR also contained CREB-IR in their nucleus. Since type 2 deiodinase activity can be induced by substances that increase cAMP, we hypothesize that DARPP-32 may regulate the activity of type 2 deiodinase by prolonging the activation of CREB. Selectivity for the colocalization of these factors to tanycytes but not the pituitary gland, may explain the heterogeneous response of type 2 deiodinase activity in these two loci in response to specific stimuli such as fasting. Themes: Endocrine and autonomic regulation. Topics: Neuroendocrine regulation: other. Copyright (C) 2000 Elsevier Science B.V.

AB - Type 2 iodothyronine deiodinase, an enzyme involved in the conversion of thyroxin to the biologically active 3,5,3'-triiodothyronine, is highly concentrated in a group of specialized ependymal cells, tanycytes, lining the wall and floor of the third ventricle. As this distribution is highly reminiscent of the distribution of cells containing the phosphatase inhibitor, DARPP-32, we raised the possibility that these two proteins may coexist in tanycytes and that DARPP-32 may modulate type 2 deiodinase activity by regulating the phosphorylation state of the cAMP regulatory factor, CREB. To address this question, double-labeling histochemical studies were performed for type 2 deiodinase mRNA and DARPP-32 immunoreactivity (IR), or DARPP-32- and CREB-IR in the same tissue sections. Type 2 deiodinase mRNA was found in the cell bodies of all DARPP-32-immunolabeled tanycytes. Both type 2 deiodinase mRNA and DARPP-32-IR also extended into tanycyte processes that ramified in the arcuate nucleus and median eminence, in close association with blood vessels and portal capillaries. In contrast, type 2 deiodinase mRNA was not present in the same cells that contained DARPP-32-IR in the pituitary gland. All tanycytes containing DARPP-32-IR also contained CREB-IR in their nucleus. Since type 2 deiodinase activity can be induced by substances that increase cAMP, we hypothesize that DARPP-32 may regulate the activity of type 2 deiodinase by prolonging the activation of CREB. Selectivity for the colocalization of these factors to tanycytes but not the pituitary gland, may explain the heterogeneous response of type 2 deiodinase activity in these two loci in response to specific stimuli such as fasting. Themes: Endocrine and autonomic regulation. Topics: Neuroendocrine regulation: other. Copyright (C) 2000 Elsevier Science B.V.

KW - CREB

KW - DARPP-32

KW - Tanycyte

KW - Type 2 iodothyronine deiodinase

UR - http://www.scopus.com/inward/record.url?scp=0342804289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0342804289&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(00)02105-3

DO - 10.1016/S0006-8993(00)02105-3

M3 - Article

C2 - 10799680

AN - SCOPUS:0342804289

VL - 862

SP - 154

EP - 161

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -